Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
88 |
|
| Actual shortage: | 1 (1%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 6 (7%) | |
| Resolved: | 80 (91%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ADREVIEW | 74MBq | SOLUTION | Resolved | 2020-09-18 | 2020-09-21 | 124542 |
| CERETEC | 0.5MG | POWDER FOR SOLUTION | Resolved | 2024-07-15 | 2024-08-22 | 232987 |
| CERETEC | 0.5MG | POWDER FOR SOLUTION KIT | Resolved | 2021-08-05 | 2021-09-09 | 143671 |
| CERETEC | 0.5MG | POWDER FOR SOLUTION KIT | Resolved | 2021-12-14 | 2022-01-01 | 151119 |
| CERETEC | 0.5MG | POWDER FOR SOLUTION KIT | Resolved | 2022-05-06 | 2022-05-12 | 160149 |
| CERETEC | 0.5MG | POWDER FOR SOLUTION KIT | Resolved | 2024-07-15 | 2024-08-31 | 232992 |
| INDIUM DTPA IN 111 | 37MBq | SOLUTION | Avoided shortage | 2020-01-28 | 2020-05-19 | 104510 |
| INDIUM DTPA IN 111 | 37MBq | SOLUTION | Resolved | 2023-03-03 | 2023-03-18 | 186110 |
| MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-05-02 | 2024-05-16 | 226858 |
| MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-08-19 | 2024-08-31 | 235488 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Resolved | 2021-07-06 | 2021-07-10 | 141914 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Resolved | 2021-08-25 | 2021-09-17 | 144584 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Resolved | 2021-11-12 | 2021-11-23 | 149202 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Resolved | 2022-06-28 | 2022-08-06 | 163556 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Resolved | 2022-12-14 | 2023-01-20 | 178377 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2019-06-06 | 2019-06-14 | 85726 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2019-06-19 | 2019-06-22 | 87081 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-07-28 | 2020-09-26 | 121295 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-26 | 122250 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-15 | 122257 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5